In order to further investigate the role of NSFL1C/AURKB in prostate cancer, we used BRCA2-deficient prostate cancer cell line PC3M-2B4 (50) xenotransplantation tumor models to test the tumor-forming ability in vivo. This evidence concerns the gene AURKB and prostate carcinoma.